First AD

Second AD

Rachna Shroff, MD, MS, FASCO, is interim clinical affairs director, associate director of Clinical Investigations, and co-lead of Gastrointestinal Clinical Research Team at The University of Arizona Cancer Center. She is also a professor in the Department of Medicine, chief of the Division of Hematology/Oncology, medical director of the Oncology Service Line, and associate dean of Clinical and Translational Research at The University of Arizona College of Medicine.

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss considering factors for immunotherapy agents in advanced biliary tract cancer.

Choosing Among IO Agents in Advanced BTC

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Updates in Treatment Strategies for Advanced Biliary Tract Cancer

OncLive News Network®

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss considering factors for immunotherapy agents in advanced biliary tract cancer.


Considering Factors When Choosing Among IO Agents in Advanced BTC